Riskpilot← Back to searchSign inGet full accessDahlemar Sterner AB
ABActiveOrg 5590803168Scheelegatan 6 Lgh 1102General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2025
SEK 248K
+11% vs 2024
EBITDA margin
100.0%
+27% vs 2024
Equity ratio
71.1%
Financial strength
Net profit 2025
SEK 392K
+156% vs 2024
| Revenue | SEK 248K | +11% |
| EBITDA | SEK 248K | +27% |
| Net profit | SEK 392K | +156% |
| Total assets | SEK 630K | +78% |
| Equity | SEK 448K | +117% |
| Employees | 1 | — |
Legal name
Dahlemar Sterner AB
Org number
5590803168
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 oktober 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultläkarverksamhet inom öppen- och slutenvård. På sikt kommer företaget även bedriva handel av fastigheter och ekonomiska instrument samt därmed förenlig verksamhet.
Address
Scheelegatan 6 Lgh 1102
Email
pdsmedab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 192 | 29 | 181 | 223 | 248 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 167 | 13 | 151 | 196 | 248 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 167 | 13 | 151 | 196 | 248 |
| Net financials | — | 6 | — | −1 | 197 |
| Profit before tax | 167 | 6 | 151 | 195 | 445 |
| Tax | −38 | −3 | −33 | −42 | −53 |
| Net profit | 129 | 3 | 118 | 153 | 392 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 346 | 300 | 299 | 354 | 630 |
| Equity | 231 | 85 | 203 | 206 | 448 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 115 | 215 | 97 | 148 | 182 |
| Total debt | 115 | 215 | 97 | 148 | 182 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
87.5%
This company
18.4%
Market median
+376% vs market
20212025
Net profit margin
158.1%
This company
8.1%
Market median
+1852% vs market
20212025
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dahlemar Sterner AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Caroline Stina Fiorella Staub | Deputy Board Member | 0 companies |
| Patrick Gustaf Michael Sterner | Board of Directors | 0 companies |